Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of March 2019. The report details a corporate action approved by the Board of Directors on March 25, 2019, regarding a capital increase resulting from the exercise of stock options under the "First Program for the year of 2014 of the Company's Stock Option Plan."
Key Financial Metrics
The filing does not provide standard operating financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data presented is specific to the capital increase transaction:
- Capital Increase Amount: BRL 79,042,714.22
- New Capital Stock: BRL 57,798,844,242.20
- Shares Issued: 4,124,599 new common shares (no par value)
- Issuance Price: BRL 19.163733061 per share
- Potential Dilution: 0.02623%
Material Changes
The primary material change is the increase in the company's capital stock and the number of outstanding shares due to the exercise of options by certain beneficiaries. The filing includes historical stock price data (adjusted for interest on shareholder's equity and dividends) for the last three years, quarters, and months, but does not explicitly analyze material changes in operational performance compared to prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It does not disclose specific risks or contingencies beyond the standard regulatory disclosure of the capital increase. The document serves strictly as a notice of the approved capital increase pursuant to Brazilian Securities and Exchange Commission Normative Ruling No. 480/09.
Investor Verification Checklist
- Verify the impact of the 0.02623% dilution on earnings per share.
- Confirm the total number of outstanding shares post-issuance (New Capital Stock: BRL 57,798,844,242.20).
- Review the historical stock price trends provided to assess the issuance price relative to market averages (90-day average: BRL 17.44).
- Note that this filing does not contain quarterly or annual financial results; refer to Form 20-F for comprehensive financial statements.